Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Cyxone

Less than 1K followers
All
Research
Press releases
3rd party
ShowingAll content types
Press release11/26/2024, 4:00 PM

Interim CFO lämnar Cyxone

Cyxone
Press release11/11/2024, 2:31 PM

BioStock: Cyxone handelsstoppades och erhöll betalningskrav

Cyxone
Regulatory press release11/8/2024, 1:06 PM

Cyxone erhåller betalningskrav om knappt 5 miljoner kronor

Cyxone

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release8/29/2024, 6:50 AM

Cyxone: Delårsrapport 2024-04-01 till 2024-06-30

Cyxone
Regulatory press release8/26/2024, 12:19 PM

Cyxone AB announces last day of trading in BTA

Cyxone
Regulatory press release8/26/2024, 12:19 PM

Cyxone AB meddelar sista dag för handel med BTA

Cyxone
Regulatory press release8/16/2024, 6:59 AM

Cyxone AB publicerar utfall i genomförd företrädesemission

Cyxone
Regulatory press release8/16/2024, 6:59 AM

Cyxone AB publishes outcome of rights issue

Cyxone
Press release8/13/2024, 7:55 AM

BioStock: Cyxones vd om värdering av läkemedelsprojekt

Cyxone
Press release8/8/2024, 8:34 AM

BioStock: Emission ska realisera nya kliniska framsteg för Cyxone

Cyxone
Press release8/1/2024, 7:37 AM

BioStock: Cyxones vd: "Väsentligt lägre risk i projektutvecklingen"

Cyxone
Regulatory press release8/1/2024, 6:45 AM

Teckningstiden i Cyxones företrädesemission inleds idag

Cyxone
Regulatory press release8/1/2024, 6:45 AM

The subscription period in Cyxone's rights issue starts today

Cyxone
Regulatory press release7/31/2024, 6:45 AM

Cyxone AB publishes investment memorandum

Cyxone
Regulatory press release7/31/2024, 6:45 AM

Cyxone AB publicerar investeringsmemorandum

Cyxone
Press release7/23/2024, 11:07 AM

BioStock: Cyxone uppdaterar utvecklingsplanen

Cyxone
Regulatory press release7/23/2024, 6:30 AM

Cyxone: Styrelsen beslutar om företrädesemission om högst cirka 23 MSEK för att finansiera fortsatt utveckling av rabeximod och T20K

Cyxone
Regulatory press release7/23/2024, 6:30 AM

Cyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K

Cyxone
Press release7/15/2024, 6:42 AM

Cyxone provides an update on its research and development program

Cyxone
Press release7/15/2024, 6:42 AM

Cyxone uppdaterar sitt forsknings- och utvecklingsprogram

Cyxone
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.